Source link : https://www.newshealth.biz/health-news/barzolvolimab-shows-promise-for-cold-urticaria-and-dermographism/
The investigational monoclonal antibody barzolvolimab significantly improved provocation test outcomes and reduced symptoms compared with placebo in patients with cold urticaria and symptomatic dermographism, according to results from a phase II trial presented at the recent American College of Allergy, Asthma & Immunology annual meeting. In this exclusive MedPage Today video, investigator Jonathan Bernstein, MD, […]
Author : News Health
Publish date : 2024-11-25 18:26:03
Copyright for syndicated content belongs to the linked Source.